The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants

Altintas, DERYA; EVLIYAOGLU, NURDAN; KILINC, B; SENAN, DI; Güneşer, S

doi:10.1007/bf00499466

The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants

Altintas D. U., EVLIYAOGLU N., KILINC B., SENAN D., Güneşer S.

EUROPEAN JOURNAL OF EPIDEMIOLOGY, cilt.12, sa.6, ss.647-648, 1996 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 12 Sayı: 6
Basım Tarihi: 1996
Doi Numarası: 10.1007/bf00499466
Dergi Adı: EUROPEAN JOURNAL OF EPIDEMIOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.647-648
Çukurova Üniversitesi Adresli: Evet

Özet

The maternal antibodies are gradually decreased at 9 to 12 months in infants. We determined the elimination period of maternal measles antibodies in 34 infants whose mothers had had a history of natural measles previously. Seropositivity rates at sixth and nine months of age were found to be 61.8% and 3.4%, respectively. The very low passive antibody at nine months of age may suggest the measles vaccination could be carried out earlier than just before the critical age of antibody level.